Systemic treatment of metastatic hormone-sensitive prostate cancer-upfront triplet versus doublet combination therapy
Standard
Systemic treatment of metastatic hormone-sensitive prostate cancer-upfront triplet versus doublet combination therapy. / Oing, C; Bristow, R G.
in: ESMO OPEN, Jahrgang 8, Nr. 2, 04.2023, S. 101194.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Editorial › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Systemic treatment of metastatic hormone-sensitive prostate cancer-upfront triplet versus doublet combination therapy
AU - Oing, C
AU - Bristow, R G
PY - 2023/4
Y1 - 2023/4
KW - Male
KW - Humans
KW - Prostatic Neoplasms/drug therapy
KW - Docetaxel
KW - Hormones
U2 - 10.1016/j.esmoop.2023.101194
DO - 10.1016/j.esmoop.2023.101194
M3 - Editorial
C2 - 36947986
VL - 8
SP - 101194
JO - ESMO OPEN
JF - ESMO OPEN
SN - 2059-7029
IS - 2
ER -